Results
|
|
25001.
|
|
|
|
25002.
|
|
|
|
25003.
|
|
|
|
25004.
|
|
|
|
25005.
|
|
|
|
25006.
|
Phase I study of high-dose continuous-infusion recombinant interleukin-2 and autologous lymphokine-activated killer cells in patients with metastatic or unresectable malignant melanoma and renal cell carcinoma. [electronic resource] by
- Gaynor, E R
- Weiss, G R
- Margolin, K A
- Aronson, F R
- Sznol, M
- Demchak, P
- Grima, K M
- Fisher, R I
- Boldt, D H
- Doroshow, J H
Producer: 19900925
In:
Journal of the National Cancer Institute vol. 82
Availability: No items available.
|
|
|
25007.
|
|
|
|
25008.
|
|
|
|
25009.
|
|
|
|
25010.
|
|
|
|
25011.
|
|
|
|
25012.
|
|
|
|
25013.
|
|
|
|
25014.
|
|
|
|
25015.
|
|
|
|
25016.
|
|
|
|
25017.
|
|
|
|
25018.
|
|
|
|
25019.
|
|
|
|
25020.
|
|